Surgical Endoscopy And Other Interventional Techniques

, Volume 17, Issue 11, pp 1833–1836

Disruptive visions: Biosurgery



There are a number of new therapeutic options generated by the biotechnology, bioengineering, and bioimaging revolutions in terms of organ-specific designer drugs, genetically engineered cells, cell-specific proteins and drugs, directed energy instruments, therapeutic microdevices, etc. Many of these new therapies need to be placed exactly on, within, or adjacent to an organ, and many others are delivered by endoluminal or endovascular approaches. The common requirements are (1) the accurate delivery of the modality and (2) the functional importance of targeting the biologic basis rather than the anatomic structure—hence the term biosurgery. As more of these therapies achieve clinical applicability and FDA approval, there will be the need for the precision of delivery to be at the micro- and nanoscale, which is well beyond human physical limitations. The surgeon of the future must be able to identify those therapeutic modalities that would benefit from such exact placement or implantation and acquire the skills, training, and equipment to use surgical expertise to deliver these new modalities. A review of some of the emerging opportunities is presented. Ignoring these challenges will relinquish these new procedures to other nonsurgical interventionalists, perhaps to the detriment of patient safety.


  1. 1.
    Feynman R (1959) There’s plenty of room at the bottom. Lecture to the American Physical Society at California Institute of Technology (Caltech), December 1959. Available at http://www. Scholar
  2. 2.
    Grikscheit, TC, Ogilvie, JB, Ochoa, ER, Alsberg, E, Mooney, D, Vacanti, JP 2002Tissue-engineered colon exhibits function in vivo.Surgery132200204CrossRefPubMedGoogle Scholar
  3. 3.
    Hammerle, H, Kobuch, K, Kohler, K, Nisch, W, Sach, H, Stelzle, M 2002Biostability of micro-photodiode arrays for subretinal implantation.Biomateriais23797804CrossRefGoogle Scholar
  4. 4.
    Lee, H, Cusick, RA, Browne, F, Ho Kim, T, Ma, PX, Utsunomiya, H, Langer, R, Vacanti, JP 2000Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices.Transplantation731589159XGoogle Scholar
  5. 5.
    Selam, JL 2001External and implantable insulin pumps: current place in the treatment of diabetes.Exp Clin Endocrinol Diabetes109S333S340Google Scholar
  6. 6.
    Serruya, MD, Hatsopoulos, NG, Paninski, L, Fellows, MR, Donoghue, JP 2002Instant neural control of movement signal.Nature416121122CrossRefGoogle Scholar
  7. 7.
    Soong, RK, Bachand, GD, Neves, HP, Olkhovets, AG, Craighead, HG, Montemagno, CD 2000Powering an inorganic nanodevice with a biomolecular motor.Science29015551558CrossRefPubMedGoogle Scholar
  8. 8.
    Tirlapur, UK, Konig, K 2002Femosecond near-infrared laser pulses as a versatile non-invasive tool for intra-tissue nanoprocessing in plants without compromising viability.Plant J31365374CrossRefPubMedGoogle Scholar
  9. 9.
    Tirlapur, UK, Konig, K 2002Targeted transfection by femtosecond laser.Nature418290291CrossRefPubMedGoogle Scholar
  10. 10.
    Vaezy, S, Martin, R, Keilman, G, Kaczkowski, P, Chi, E, Yazaji, E, Caps, M, Poliachik, C, Carter, S, Sharar, S, Comejo, C, Crum, L 1999Control of splenic bleeding by using high intensity focused ultrasound.J Trauma47521525PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  1. 1.Department of SurgeryUniversity of Washington School of Medicine, 1959 NE Pacific Street, Seatle WA 98195USA
  2. 2.Advanced Biomedical TechnologiesDefense Advanced Research Projects Agency (DARPA), Arlington, VAUSA
  3. 3.Department of SurgeryOhio State University Medical Center, Minimally Invasive Cardiac Surgery and Robotics, Columbus, OHUSA

Personalised recommendations